logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
Back
L

Linong Ji

Peking University People's Hospital

48H-index
409Paper Count
1.2WCitation Count
Published Papers 210
Publication Date
logo
Efficacy and Hypoglycaemia Outcomes With Once-Weekly IcoSema Versus Comparators in Individuals With Type 2 Diabetes by Kidney and Liver Function: A Post Hoc Analysis of the COMBINE 1–3 Trials
errDIABETES OBESITY & METABOLISM
IF5.7
err2026-08-11
err0
errOAAI
errLinong Ji; Jonas Dahl Andersen; Malik Benamar; Paola Ponzani; A. G. Unnikrishnan; Siri Vinther; Rosangela Rea
errShare
errSave
Evaluation of the Safety, Efficacy and Pharmacokinetics of BGM0504 in Chinese Adults With Type 2 Diabetes: A Multicentre, Randomised, Controlled and Double-Blind Phase II Trial
errdiabetes, obesity and metabolism
IF0
err2026-05-31
err0
errOAAI
errPing Jin; Linong Ji; Yangqing Huang; Haifeng Ding; Daosheng Xie; Xiaohui Jiang; Xuemei Yuan; Zhao Cao; Haibin Zhang; Jiandong Yuan
errShare
errSave
Distribution of HbA1c Levels in Patients With GCK-MODY: A Worldwide Literature-Based Retrospective Analysis
errdiabetes, obesity and metabolism
IF0
err2026-05-11
err0
PREAI
errYihan Zhao; Tianhao Ba; Yinkun Yan; Yilin Zhao; Yufeng Li; Xianghai Zhou; Qian Ren; Xueyao Han; Linong Ji
errShare
errSave
Impact of Simulated Risk Factor Management on Cardiovascular Disease and Costs in Type 2 Diabetes Using the ABC Model
errdiabetes, obesity and metabolism
IF0
err2026-04-13
err0
errOAAI
errLee-Ling Lim; Eric S. H. Lau; Juliana N. M. Lui; Linong Ji; A. G. Unnikrishnan; Sirinart Sirinvaravong; Siew-Pheng Chan; Soo Lim; Andrea O. Y. Luk; Juliana C. N. Chan
errShare
errSave
A Four-Variant T1D Genetic Risk Score to Classify Type 1 and Monogenic Diabetes in Chinese Patients
errdiabetes, obesity and metabolism
IF0
err2026-03-19
err0
PREAI
errWei Liu; Ruiqing Xing; Xiaoling Cai; Yu Zhu; Qian Ren; Simin Zhang; Siqian Gong; Rui Zhang; Ying Gao; Mingxia Zhang; Sai Yin; Juan Li; Yongran Huo; Xueyao Han; Linong Ji
errShare
errSave
CGM-derived efficacy and overall safety of once-weekly insulin efsitora alfa (efsitora) relative to day of administration in adults with type 2 diabetes
errdiabetes, obesity and metabolism
IF0
err2026-01-22
err0
errOAAI
errThomas Martens MD; Tadej Battelino MD; Simon Heller BM; Anuj Bhargava MD; Linong Ji; Sreenivasa Murthy MD; Rebecca J. Threlkeld MS; Xiaoqi Li PhD; Ada Leticia Murro MD; Kristen Syring PhD; Vidhi Patel PharmD
errShare
errSave
Utility of continuous glucose monitoring in people with type 2 diabetes on insulin-based regimens in clinical practice: A case series and expert opinion
errDiabetes Research and Clinical Practice
IF7.4
err2025-12-13
err0
PREAI
errSoo Lim; Rimei Nishimura; Jothydev Kesavadev; Alice Pik Shan Kong; Margaret J McGill; Horng-Yih Ou; Chun-Kwan O; Chun-Chuan Lee; Xiaomei Zhang; Linong Ji; Chih-Yuan Wang
errShare
errSave
Real-World Effectiveness of Insulin Glargine 300 U/ml in People with Type 2 Diabetes Previously Treated with Tirzepatide: The DELIVER-T Study
errDiabetes Therapy
IF2.6
err2025-11-21
err0
errOAAI
errRobert Ritzel; Melanie J. Davies; Lichen Hao; Linong Ji; Lintu MK; Aileen Mabunay; Didac Mauricio; Timothy Bailey
errShare
errSave
Heterogeneous Covariates-Aware Pseudo Supervised Meta-Learning for Few-Shot Diabetes Classification
errIEEE Transactions on Computational Biology and Bioinformatics
IF0
err2025-11-01
err0
PREAI
errWang, Lei; Liu, Wei; Cai, Deheng; Ji, Linong; Shi, Dawei; Yao, Ke; Yang, Qian
errShare
errSave
Mazdutide versus Semaglutide for the treatment of type 2 diabetes and obesity: Rationale, design and baseline data of DREAMS-3 phase 3 trial
errCONTEMPORARY CLINICAL TRIALS
IF1.9
err2025-11-01
err1
PREAI
errLuo, Yingying; Jiang, Hongwei; Shi, Bimin; Cai, Hanqing; Wang, Haifang; Li, Shu; Qiu, Wei; Li, Yunfeng; Zhou, Runze; Deng, Huan; Guo, Qun; Li, Li; Pei, Lijuan; Zhang, Han Han; Qian, Lei; Ji, Linong
errShare
errSave
Reevaluating the causal link between liver fat and hyperglycaemia
errDiabetes, Obesity and Metabolism
IF0
err2025-10-06
err0
PREAI
errZhaoqian Xu MM; Qi Huang MD; Xinlei Zhang MD; Song Wang MD; Yingying Luo MD; Feng Liu PhD; Linong Ji MD; Xiantong Zou MD
errShare
errSave
The predictive value of serum MHR combined with classical metabolic syndrome components in the first trimester for gestational metabolic syndrome: a prospective cohort study in China
errFrontiers in Medicine
IF3
err2025-10-01
err0
errOAAI
errSixu Xin; Linong Ji; Xiaomei Zhang; Yuehan Ma; Xin Zhao; Ning Yuan; Jianbin Sun; Dan Zhao
errShare
errSave
Addressing unmet needs for chronic kidney disease treatment in type 1 diabetes: A review
errDIABETES OBESITY & METABOLISM
IF5.7
err2025-10-01
err0
PREAI
errTuttle, Katherine R.; Ji, Linong; Mathieu, Chantal; Rosen, Jonathan
errShare
errSave
Regional, age-specific and sex-specific trends in the prevalence of overweight or obesity in type 1 diabetes from 1980 to 2020: a meta-analysis of 78 observational studies with 650,265 participants
errDiabetes Research and Clinical Practice
IF7.4
err2025-09-14
err0
PREAI
errYuchen Guo; Chu Lin; Xiaoling Cai; Han Wu; Jingya Yan; Zonglin Li; Ruoyang Jiao; Shuzhen Bai; Wenjia Yang; Fang Lv; Linong Ji
errShare
errSave
GRADE Notes 6: Three strategies to determine the clinically important thresholds for outcomes in evidence-based guideline development
errJournal of Clinical Epidemiology
IF5.2
err2025-09-14
err0
PREAI
errXiaomei Yao; Jun Xia; Marisa Deodat; Peiyao Wang; Yaping Chang; Yingying Luo; Linong Ji
errShare
errSave
Long-term efficacy and safety of tirzepatide in participants with type 2 diabetes with inadequate glycaemic control on metformin and/or sulfonylurea: Post-hoc analysis of SURPASS-4
errdiabetes obesity metabolism
IF0
err2025-09-09
err0
errOAAI
errHaixia Guan PhD; Hongwei Jiang PhD; Huijuan Yuan PhD; Jie Sun PhD; Jiawei Xu PhD; Linong Ji PhD
errShare
errSave
Efficacy and safety benefits of HR17031, a fixed-ratio combination of INS068 and noiiglutide, versus its components alone in Chinese patients with type 2 diabetes uncontrolled on oral antidiabetic drug(s): A phase 2, multicentre, open-label, randomised, parallel three-arm, treat-to-target trial
errdiabetes obesity metabolism
IF0
err2025-08-27
err0
PREAI
errLinong Ji PhD; Debing Huang Master; Xiang Lin Master; Xue Dong Master; Lu Li PhD; Qingyuan Sun Master; Xiaodong Sun PhD; Li Mao PhD; Shi Zhao Bachelor; Quanren Wang PhD; Zi Ye PhD
errShare
errSave
Efficacy and safety of oral semaglutide in Chinese participants with type 2 diabetes: Subgroup analyses by baseline characteristics in the PIONEER 11 and 12 randomised controlled trials
errdiabetes obesity metabolism
IF0
err2025-08-22
err0
errOAAI
errLinong Ji MD; Guoyue Yuan MD; Jun Liu MD; Bingjie Zhang MD; Wenyan Liu MMed; Zewei Shen MSc
errShare
errSave
Efficacy and safety of chiglitazar add-on to metformin in type 2 diabetes mellitus (RECAM study)
errdiabetes obesity metabolism
IF0
err2025-08-22
err0
PREAI
errLeili Gao MD; Linong Ji MD; Xin Yan MD; Zhifeng Cheng MD; Xin Zhang MD; Wenli Sun MD; Jianhua Ma MD; Weihong Song MD; Yu Liu MD; Xiaohong Lin MD; Wuyan Pang MD; Haixiang Cao MD; Bo Chen PhD; Zhibin Li PhD; Xianping Lu PhD; the RECAM Study Group
errShare
errSave
Association between estimated glucose disposal rate and lower extremity arterial disease in type 2 diabetes: A nationwide cross-sectional study from China
errdiabetes obesity metabolism
IF0
err2025-06-09
err0
PREAI
errXiaowei Wei MS; Jie Zhao PhD; Ping Zhu MBBS; Wenfang Niu MS; Zhangrong Xu MD; Xingwu Ran MD; Xiaomei Zhang MD; Aihong Wang MD; Linong Ji MD
errShare
errSave

Research Directions

No research directions
Co-authors
Cooperation Journals
F
Frank B. Hu
H-index: 244 · Papers: 1.9K
T
Tien Yin Wong
H-index: 208 · Papers: 3.1K
R
Ruth J. F. Loos
H-index: 171 · Papers: 1.2K
K
Kamlesh Khunti
H-index: 162 · Papers: 2.1K
J
Jiang He
H-index: 145 · Papers: 1.3K
View more